Stock chart
Analyses on Medi Tower (5)
- May 21, 2026
- March 27, 2026March 27, 2026
- Follow-up
Migdaley Hayam Hatichon: Neve Eyalon, Sde Dov, and How Much of the Value Is Actually Accessible
Migdaley Hayam Hatichon's development layer already contains created value, but only a limited part of it is accessible today to listed shareholders. Neve Eyalon is further advanced and better financed, yet most of its value still sits behind execution and leverage, while Sde Do…
- Follow-up
Migdaley Hayam Hatichon: Rehovot Between the Lease-Up Ramp and the Contractor Claim
Rehovot crossed a first proof point in 2025, with 66% occupancy at year-end and fourth-quarter NOI at break-even, but the stronger read also depended on one-off support from the contractor guarantees. That makes 2025 proof of an operating start, not yet proof of a stabilized hou…
- Follow-up
Migdaley Hayam Hatichon: Resident Liabilities and the Real Cash Margin After Rehovot
In 2025, Migdaley Hayam Hatichon did not face an immediate NIS 2.77 billion liquidity wall, but it also did not yet build a broad recurring cash cushion at group level. Almost all of the improvement in cash flow and AFFO came from first occupancy in Rehovot, while the mature net…
Migdaley Hayam Hatichon 2025: Rehovot Is Pushing FFO Up, but the Occupancy and Funding Test Is Just Starting
Migdaley Hayam Hatichon looks stronger in 2025 because Rehovot started flowing deposits and pushed AFFO and operating cash sharply higher, but the real test has now shifted to whether Rehovot can keep leasing up fast enough to support the next growth layer without leaning on gro…
More companies in Investment-Properties In Israel (58)
